about
Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelCarboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanismFactors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.Modifying the tumor microenvironment using nanoparticle therapeuticsA Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer.Comparison of Tumor Penetration of Podophyllotoxin-Carboxymethylcellulose Conjugates with Various Chemical Compositions in Tumor Spheroid Culture and In Vivo Solid Tumor.Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy.Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach.Synthesis of a Gemcitabine Prodrug for Remote Loading into Liposomes and Improved Therapeutic Effect.Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria.Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalizationChitosan-Chondroitin sulfate based polyelectrolyte complex for effective management of chronic wounds
P50
Q27010654-34158E4A-8EC2-4FA2-A03B-A9DCB547A776Q34005719-3FE249F2-1C70-49F0-8D27-D93201E186EFQ35232504-9619037A-C35F-4BA5-B401-BC90F80E79C2Q35642480-B2926266-665E-493E-9798-17229B8BC0A0Q37476252-AFCD432B-D836-4587-8641-BA49412EC982Q38796320-069C6739-A03A-489A-81D7-11ECD590662DQ38804342-70C3D5F2-5397-458E-8A8A-D15CDFBF4ADCQ38823177-BF671E83-CACB-4B3E-9C3E-355D9EA8E302Q39356108-BDB49E4C-3C13-451F-95AC-40D6B2ED8ACAQ39658753-14847143-7384-4D26-A481-385FF269D2F8Q50901890-25D1C806-F80E-4500-A9C0-BB4988CEDCEAQ52666954-77582AE3-7A61-4A89-BB72-F927C6317B50Q53695205-3F3301F9-2E8B-4831-93B5-A193214424CAQ53739408-4D2A8576-D7A5-435D-990F-D5317D684F8EQ91055471-F66878FD-D750-42C6-8D9C-E8FF66A16DEFQ92706487-3DA18847-22B9-4FD7-8BC8-D2E404316C5B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Aniruddha Roy
@en
Aniruddha Roy
@nl
type
label
Aniruddha Roy
@en
Aniruddha Roy
@nl
prefLabel
Aniruddha Roy
@en
Aniruddha Roy
@nl
P31
P496
0000-0003-3374-421X